{
    "sec_cik": "0000899866",
    "sec_company_name": "ALEXION PHARMACEUTICALS, INC. (Filer)",
    "document_type": "10K",
    "sec_form_header": "Form 10-K",
    "sec_period_of_report": "20191231",
    "sec_filing_date": "20200204",
    "sec_changed_date": "20200204",
    "sec_accepted_date": "20200204063053",
    "sec_index_url": "https://www.sec.gov//Archives/edgar/data/899866/000089986620000012/0000899866-20-000012-index.htm",
    "sec_url": "https://www.sec.gov//Archives/edgar/data/899866/000089986620000012/0000899866-20-000012.txt",
    "metadata_file_name": "C:\Users\aaron\OneDrive\Desktop\homework\finance2\SEC-EDGAR-text\output_files_examples\batch_0014\003\ALXN_0000899866_10K_20191231_Item7_metadata.json",
    "original_file_name": "",
    "original_file_size": "4682570 chars",
    "document_group": "10-K",
    "section_name": "Item7",
    "section_n_characters": 86337,
    "endpoints": [
        "Item 7.MANAGEMENTâ€™S DISCUSSION AND ANALYSIS OF FINANCIAL CONDITION AND RESULTS OF OPERATIONS.",
        "Item 7A.QUANTITATIVE AND QUALITATIVE DISCLOSURES ABOUT MARKET RISK."
    ],
    "extraction_method": "xbrl",
    "warnings": [],
    "company_description": "ALXN",
    "output_file": "C:\Users\aaron\OneDrive\Desktop\homework\finance2\SEC-EDGAR-text\output_files_examples\batch_0014\003\ALXN_0000899866_10K_20191231_Item7_excerpt.txt",
    "time_elapsed": 1.1,
    "batch_number": 14,
    "batch_signature": "",
    "batch_start_time": "2023-04-27 17:58:20.997894",
    "batch_machine_id": "DESKTOP-BTCJU5K",
    "section_end_time": "2023-04-27 18:15:27.271756"
}